Mauna Kea Technologies Quote - ALMKT

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.172

Bid

0.172

Offer

0.175

Volume

62,449

0.171 Day's Range 0.1748

0.162 52 Week Range 0.525

Market Cap

10.595M

Previous Close

0.172

Open

0.1746

Last Trade

569

0.172

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

106,009

Shares Outstanding

61,598,117

Dividend Yield

PE Ratio

-6.12

Earnings Per Share (EPS)

-0.06

Revenue

18.14M

Net Profit

-3.73M

Sector

Home Health Care Services

Industry

Home Health Care Services

Website

www.maunakeatech.com

Headquarters

Paris, Paris, Fra

Founded

Mauna Kea Technologies SA is listed in the Home Health Care Services sector of the Euronext with ticker ALMKT. The last closing price for Mauna Kea Technologies was 0.17 €. Over the last year, Mauna Kea Technologies shares have traded in a share price range of 0.162 € to 0.525 €.

Mauna Kea Technologies currently has 61,598,117 shares in issue. The market capitalisation of Mauna Kea Technologies is 10.59 € million. Mauna Kea Technologies has a price to earnings ratio (PE ratio) of -6.12.

Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Article L233-8-II of the Commercial Code Article 223-16 of the General Regulations of the AMF Regulatory News: Mauna Kea Technologies...

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers

Cellvizio was successfully integrated into TransOral Robotic Surgery (TORS) procedures to assess peripheral mucosal margins in the larynx...

MAUNA KEA TECHNOLOGIES : BILAN SEMESTRIEL S2 2024 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT

Regulatory News: Au titre du contrat de liquidité confié par la société MAUNA KEA TECHNOLOGIES (Paris:ALMKT) à la Société de Bourse Gilbert...

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex

13th U.S. AI patent awarded to Mauna Kea Expanded patent portfolio boosts platform value, supports strategic partnerships Regulatory News: Mauna...

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update

Full Year Sales excluding licenses of €5.6m, down 9% YoY amid delayed capital sales and no revenue from JV in China Two specialized investment...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.004	-2.27272727273	0.176	0.18	0.1706	69564	0.17200698	DE
4	-0.007	-3.91061452514	0.179	0.2	0.166	109907	0.18043857	DE
12	-0.021	-10.8808290155	0.193	0.205	0.162	106009	0.17669088	DE
26	-0.2005	-53.8255033557	0.3725	0.388	0.162	143113	0.26882552	DE
52	-0.298	-63.4042553191	0.47	0.525	0.162	157820	0.35200337	DE
156	-0.448	-72.2580645161	0.62	0.63	0.162	137640	0.38658897	DE
260	-0.448	-72.2580645161	0.62	0.63	0.162	137640	0.38658897	DE

ALMKT - Frequently Asked Questions (FAQ)

What is the current Mauna Kea Technologies share price?

The current share price of Mauna Kea Technologies is 0.172 €

How many Mauna Kea Technologies shares are in issue?

Mauna Kea Technologies has 61,598,117 shares in issue

What is the market cap of Mauna Kea Technologies?

The market capitalisation of Mauna Kea Technologies is EUR 10.59M

What is the 1 year trading range for Mauna Kea Technologies share price?

Mauna Kea Technologies has traded in the range of 0.162 € to 0.525 € during the past year

What is the PE ratio of Mauna Kea Technologies?

The price to earnings ratio of Mauna Kea Technologies is -6.12

What is the cash to sales ratio of Mauna Kea Technologies?

The cash to sales ratio of Mauna Kea Technologies is 1.26

What is the reporting currency for Mauna Kea Technologies?

Mauna Kea Technologies reports financial results in EUR

What is the latest annual turnover for Mauna Kea Technologies?

The latest annual turnover of Mauna Kea Technologies is EUR 18.14M

What is the latest annual profit for Mauna Kea Technologies?

The latest annual profit of Mauna Kea Technologies is EUR -3.73M

What is the registered address of Mauna Kea Technologies?

The registered address for Mauna Kea Technologies is 9 RUE D'ENGHIEN, PARIS, PARIS, 75010

What is the Mauna Kea Technologies website address?

The website address for Mauna Kea Technologies is www.maunakeatech.com

Which industry sector does Mauna Kea Technologies operate in?

Mauna Kea Technologies operates in the HOME HEALTH CARE SERVICES sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ALCABCabasse SA	2.00 € (48.15%)	55.52k
BAIOdyssey Acquisition SA	0.19 € (46.72%)	360.74k
ALMASMastrad	0.0278 € (46.32%)	6.83M
BIOSBiosenic	0.0048 € (33.33%)	54.34M
ALVAZVaziva SA	42.00 € (29.63%)	684
MLBSPBlue Shark Power System SA	5.70 € (-26.92%)	89
COTYCoty Inc	5.62 € (-15.99%)	18.76k
EBUSEbusco Holding NV	0.638 € (-15.50%)	2.41M
MLMGLAction Magillem Design Services	2.20 € (-15.38%)	5
MLBMDBeaconsmind AG	6.80 € (-15.00%)	1.04k
ATOAtos SE	0.0025 € (8.70%)	3.86B
BCPBanco Comercial Portugues SA	0.5064 € (-0.39%)	63.74M
BIOSBiosenic	0.0048 € (33.33%)	54.34M
ALVERVergnet	0.0006 € (0.00%)	36.31M
ALCYBCybergun	0.0001 € (0.00%)	17.38M

Trooperstocks 1 minute ago

CEO and Founder Tony Raynor shared insights about SGTM’s mission and partnerships during an engaging interview with New to The Street’s TV Host, Jane King, at the Nasdaq MarketSite Studio.
https://img1.wsimg.com/isteam/ip/9f8df632-1291-4de6-ae2e-6cd4239755a5/IMG_3533.jpeg/:/cr=t:0%25,l:0%25,

SGTM

JohnnyMakeBucks 1 minute ago

lol I see. Let’s beat up the company we supposedly own shares in to front load. Nice try. You’re gonna have to hit the ask.

IDVV

FROZENFLAME 1 minute ago

I think we should have a PR soon, can't wait !

BRLL

pos_stock_hoarder 1 minute ago

Joe Biden asks if he can pardon the pos retroactively!!!!

vlispxpert 1 minute ago

STFS 3 week rule, toss out 3 days LMAOOO:

https://schrts.co/aCmzerQM

The Assm An 2 minutes ago

Think or swim just had a spasm

IGPK

NoScaredMoneyHere 2 minutes ago

I’m certain that the company knows holders doubts.. just look at the responses to the tweet. It would be great if they dropped a tweet saying no RS but doubt they will..🤷🏽‍♂️.. as someone said, it’s in their court

GRLF

nickeli54 2 minutes ago

No RS but thanks for chiming in smh

AAGC

SLJB 2 minutes ago

Obi-Wan Kenobi, you're BACK ! :)

FNMA

jimmy051357 2 minutes ago

Don't know what the incredible news is yet, other than we hooked up with Pineapple Express somehow.

PNXP

linkvest 2 minutes ago

MMs are crooks

IGPK

dexprs 2 minutes ago

Good move Elroy. It is reporting in 6 days, what do you expect?

Nelson2 2 minutes ago

Dude! You’re funnier when you’re making money!
Sounds familiar!
GLTU

ANTI-BAGHOLDER 2 minutes ago

Pretty shocked more people are on to this to be honest.

PYYX

WorstLuck 3 minutes ago

It's only interesting to me because BIIB shouldn't need to be searching for that kind of money under the couch cushions. Are they actively trying to reduce debt leverage?

DocLee 3 minutes ago

It looks like this new trial is the one that appeared in a report in last Friday's on-line medical publication, "Doctors.net", prepared by PA Media, puffing up a new trial on GBM being conducted by Queen Mary University, London and Bart's (ie St. Bartholomew's) Brain Tumour Centre. Its stated aim i

NWBO

dewophile 3 minutes ago

Some of that is because large pharmas like JNJ have decided to stop RSV for “strategic reasons” which can be bc they don’t see the opportunity. However many of these companies - throw PFE in their- had either subpar drugs or were trying to recruit during the pandemic when RSV was non existent or bo

JNJ PFE

findit 3 minutes ago

Thanks for putting me onto it. A little step back now. Think more to come.

davidsson10 4 minutes ago

https://people.com/elizabeth-holmes-breaks-her-silence-in-first-interview-from-prison-it-s-been-hell-and-torture-exclusive-8789737

PEACHMAN 4 minutes ago

Could not have summarized it better

He had my vote

lovethatgreen 4 minutes ago

Took a few 3s

AFFU

AFFU

Drugdoctor 4 minutes ago

Another 🤡 prediction from a non-shareholder, lmao.

GVSI

Cassius Longinus 4 minutes ago

Been loading for over a year now. Up to 5k shares.

PYYX

budfoxfun 4 minutes ago

The SGTM-VRM offers innovative solutions for managing diseases, reducing the reliance on chemical interventions. Moreover, their formulations promote the biological fixation of essential nutrients, enhancing soil remediation and supporting large-scale agriculture.

SGTM

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Mauna Kea Technologies SA (ALMKT)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Mauna Kea Technologies SA

Ask ADVFN Intelligence (AI)

ALMKT Latest News

Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers

MAUNA KEA TECHNOLOGIES : BILAN SEMESTRIEL S2 2024 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update

Mauna Kea Technologies : Information relative au nombre total de droits de vote et d’actions composant le capital social

Mauna Kea Technologies annonce des résultats prometteurs pour une nouvelle application combinant robotique et Cellvizio® pour la chirurgie de précision des cancers de la tête et du cou

MAUNA KEA TECHNOLOGIES : BILAN SEMESTRIEL S2 2024 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT

Mauna Kea Technologies obtient un nouveau brevet américain en intelligence artificielle, renforçant son portefeuille de propriété intellectuelle dans l'endomicroscopie

Mauna Kea Technologies publie son chiffre d’affaires pour l’année 2024 et fait le point sur son process stratégique

Mauna Kea Technologies publie son calendrier financier 2025

Mauna Kea Technologies : Information relative au nombre total de droits de vote et d’actions composant le capital social

Mauna Kea Technologies : Information relative au nombre total de droits de vote et d’actions composant le capital social

ALMKT - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Mauna Kea Technologies SA (ALMKT) Share Price

Mauna Kea Technologies SA (ALMKT)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Mauna Kea Technologies SA

Ask ADVFN Intelligence (AI)

ALMKT Latest News

Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers

MAUNA KEA TECHNOLOGIES : BILAN SEMESTRIEL S2 2024 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT

Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex

Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update

Mauna Kea Technologies : Information relative au nombre total de droits de vote et d’actions composant le capital social

Mauna Kea Technologies annonce des résultats prometteurs pour une nouvelle application combinant robotique et Cellvizio® pour la chirurgie de précision des cancers de la tête et du cou

MAUNA KEA TECHNOLOGIES : BILAN SEMESTRIEL S2 2024 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE GILBERT DUPONT

Mauna Kea Technologies obtient un nouveau brevet américain en intelligence artificielle, renforçant son portefeuille de propriété intellectuelle dans l'endomicroscopie

Mauna Kea Technologies publie son chiffre d’affaires pour l’année 2024 et fait le point sur son process stratégique

Mauna Kea Technologies publie son calendrier financier 2025

Mauna Kea Technologies : Information relative au nombre total de droits de vote et d’actions composant le capital social

Mauna Kea Technologies : Information relative au nombre total de droits de vote et d’actions composant le capital social

ALMKT - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free